Bottom of the range looks a good place to buy GSK.
Underperforming though and needs some impetus for share price growth.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.